Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
5% Minoxidil Foam With or Without Microneedling for Alopecia Areata
ChiCTR2600126353Phase 4Not yet recruiting
- Sponsor
- Third Xiangya Hospital, Central South University
- Start
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of minoxidil in alopecia areata, alopecia areata totalis (AT) and alopecia universalis (AU) (2 arms), sponsored by Third Xiangya Hospital, Central South University. Primary endpoints: SALT50 response rate at 12 weeks and Mean hair regrowth percentage at 12 weeks. Planned start Jun 2026; status: not yet recruiting.
02
Drugs
minoxidil
03
Conditions
alopecia areataalopecia areata totalis (AT)alopecia universalis (AU)
Beyond the preview
Go deeper on ChiCTR2600126353.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600126353.